Phibro Animal Health Corp
PAHC40.060USD
+0.190+0.48%
Handelsschluss 01/15, 16:00（ET）Kurse um 15 Minuten verzögert
1.62BMarktkapitalisierung
23.94KGV TTM
mehr Informationen über Phibro Animal Health Corp Unternehmen
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Phibro Animal Health Corp Informationen
BörsenkürzelPAHC
Name des UnternehmensPhibro Animal Health Corp
IPO-datumApr 11, 2014
CEOBendheim (Jack C)
Anzahl der mitarbeiter2475
WertpapierartOrdinary Share
GeschäftsjahresendeApr 11
AddresseGlenpointe Centre East, 3Rd Floor
StadtTEANECK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07666
Telefon12013297300
Websitehttps://www.pahc.com/
BörsenkürzelPAHC
IPO-datumApr 11, 2014
CEOBendheim (Jack C)
Führungskräfte von Phibro Animal Health Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
Nach RegionUSD
Name
Umsatz
Anteil
United States
202.35M
55.61%
Latin America and Canada
87.23M
23.97%
Europe & Middle East & Africa
44.94M
12.35%
Asia Pacific
29.38M
8.07%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
Aktionärsstatistik
Aktualisiert: Tue, Nov 18
Aktualisiert: Tue, Nov 18
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
Andere
67.35%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
Andere
67.35%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
55.65%
Investment Advisor/Hedge Fund
29.60%
Hedge Fund
8.81%
Research Firm
3.30%
Pension Fund
1.72%
Individual Investor
0.52%
Bank and Trust
0.46%
Corporation
0.19%
Sovereign Wealth Fund
0.05%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
421
20.39M
99.73%
-3.12M
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
2.92M
14.28%
-23.05K
-0.78%
Sep 30, 2025
The Vanguard Group, Inc.
1.52M
7.44%
-22.54K
-1.46%
Sep 30, 2025
State Street Investment Management (US)
894.04K
4.37%
-15.29K
-1.68%
Sep 30, 2025
Acadian Asset Management LLC
785.82K
3.84%
+61.38K
+8.47%
Sep 30, 2025
Renaissance Technologies LLC
555.20K
2.72%
-55.60K
-9.10%
Sep 30, 2025
Geode Capital Management, L.L.C.
547.16K
2.68%
-7.77K
-1.40%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
485.51K
2.37%
-71.73K
-12.87%
Sep 30, 2025
Nuveen LLC
478.02K
2.34%
+19.45K
+4.24%
Sep 30, 2025
Fidelity Management & Research Company LLC
413.62K
2.02%
+354.02K
+594.03%
Sep 30, 2025
Castleknight Management LP
399.78K
1.96%
-131.56K
-24.76%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
AAM Sawgrass US Small Cap Quality Growth ETF
2.49%
State Street SPDR S&P Pharmaceuticals ETF
1.19%
Innovator IBD 50 Fund ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
1.06%
Inspire Fidelis Multi Factor ETF
1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.02%
Lattice Hartford Multifactor Small Cap ETF
0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.61%
Invesco S&P SmallCap Health Care ETF
0.52%
Mehr Anzeigen
AAM Sawgrass US Small Cap Quality Growth ETF
Anteil2.49%
State Street SPDR S&P Pharmaceuticals ETF
Anteil1.19%
Innovator IBD 50 Fund ETF
Anteil1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
Anteil1.06%
Inspire Fidelis Multi Factor ETF
Anteil1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Anteil1.02%
Lattice Hartford Multifactor Small Cap ETF
Anteil0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil0.76%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.61%
Invesco S&P SmallCap Health Care ETF
Anteil0.52%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
97.20M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 04, 2025
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 17, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 17, 2025
Nov 26, 2025
Jul 29, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 24, 2025 going ex on Sep 03, 2025
Sep 03, 2025
Sep 24, 2025
Sep 03, 2025
May 06, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 25, 2025 going ex on Jun 04, 2025
Jun 04, 2025
Jun 25, 2025
Jun 04, 2025
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
Mehr Anzeigen
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Phibro Animal Health Corp?
Die fünf größten Anteilseigner von Phibro Animal Health Corp sind:
BlackRock Institutional Trust Company, N.A. hält 2.92M Aktien, was 14.28% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 1.52M Aktien, was 7.44% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 894.04K Aktien, was 4.37% der Gesamtaktien entspricht.
Acadian Asset Management LLC hält 785.82K Aktien, was 3.84% der Gesamtaktien entspricht.
Renaissance Technologies LLC hält 555.20K Aktien, was 2.72% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 2.92M Aktien, was 14.28% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 1.52M Aktien, was 7.44% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 894.04K Aktien, was 4.37% der Gesamtaktien entspricht.
Acadian Asset Management LLC hält 785.82K Aktien, was 3.84% der Gesamtaktien entspricht.
Renaissance Technologies LLC hält 555.20K Aktien, was 2.72% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Phibro Animal Health Corp?
Die drei wichtigsten Anteilseigner-Typen von Phibro Animal Health Corp sind:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an Phibro Animal Health Corp (PAHC)?
Mit Stand vom 2025Q4 halten 421 Institutionen Anteile an Phibro Animal Health Corp, mit einem Gesamtmarktwert von etwa 20.39M, was 99.73% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -7.02% gestiegen.
Was ist die größte Einnahmequelle von Phibro Animal Health Corp?
Am FY2026Q1 erzielte das Geschäft mit MFAs and Other für Phibro Animal Health Corp den höchsten Umsatz in Höhe von 195.20M, was 53.64% des Gesamtumsatzes entspricht.
